News-Medical.Net November 4, 2024
Oregon Health & Science University

For generations, the federal government has largely refrained from paying for mental health and substance use treatment in large residential facilities.

That changed in 2015 when, in response to increasing overdose deaths nationwide from illicit drugs, the federal government allowed states to waive a longstanding prohibition against using federal Medicaid funding for services in so-called institutions of mental diseases. In turn, states were required to improve their addiction care with an emphasis on increasing treatment with medications.

Yet a new study by researchers at Oregon Health & Science University finds no overall benefit in terms of increased treatment or decrease in nonfatal overdoses among the 17 states that received those waivers between 2017 and 2019, compared with 18 that did...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicaid, Patient / Consumer, Provider, Survey / Study, Trends
Redesigning Integrated Care For Dually Eligible People With Intellectual/Developmental Disabilities
Medicaid spending on weight loss, diabetes drugs up 500% since 2019: 5 numbers to know
CMS Launches New Program for Mental Health, OUD Treatment
Georgia Medicaid shakeup could force 3 in 4 beneficiaries to change plans: Centene CEO
New Center to Coordinate Between Medicaid, Maternal and Child Health

Share This Article